Shares of Thermo Fisher Scientific Inc. (TMO) were in the spotlight on Wednesday after the company reported upbeat first-quarter (Q1) earnings but slashed its annual earnings guidance. For the three ...

(a) Adjusted results exclude accelerated depreciation on manufacturing assets to be abandoned due to facility consolidations. Adjusted results in 2025 exclude $5 of charges for the sale of inventory ...

The "Enterprise Tech Ecosystem Series: Thermo Fisher Scientific - 2025" company profile has been added to ResearchAndMarkets.com's offering. The report offers detailed information and insights into ...

Fintel reports that on December 15, 2025, Wells Fargo maintained coverage of Thermo Fisher Scientific (NYSE:TMO) with a ...

Reports Q3 revenue $10.6B, consensus $10.64B. “We are pleased to deliver strong financial results in the third quarter, reflecting another quarter of sequential improvement in growth,” said Marc N.

Thermo Fisher Scientific Inc. TMO is slated to release third-quarter 2021 results on Oct 20, before market open. In the last reported quarter, the company’s earnings of $5.60 per share exceeded the ...

Second quarter revenue grew 3% to $10.85 billion. Second quarter GAAP diluted earnings per share (EPS) grew 6% to $4.28. Second quarter adjusted EPS was $5.36. Delivered excellent operational ...

(a) Adjusted results exclude accelerated depreciation on manufacturing assets to be abandoned due to facility consolidations. Adjusted results in 2025 exclude $10 of charges for the sale of inventory ...

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), we use certain non-GAAP financial measures such as organic revenue growth, which is ...